Marina and Chris have both joined the OHE in October 2017. Marina joins following completion of her MSc in Health Economics (City, University of London) and Chris joins from the University of Nottingham.
Drug prices in the US might overstate pharmaceuticals' long-run cost up to 75%. True long-term costs then must be considered by market access and policy decisions.
